Information was received from a patient who was implanted with an implantable neurostimulator (ins) for gastrointestinal/pelvic floor and urinary dysfunction/sacral nerve stim.It was reported that the patient (pt) is wondering if they should adjust therapy setting as pt reported they have been "going a lot" and have had a return of symptoms.The agent tried to clarify if the pt is getting a 50% reduction in symptoms, but the pt did not answer.The pt inquired about the number of available programs.The pt stated they adjusted stim on the 23rd.Walked pt through how to change programs on the call and the pt successfully changed programs.The pt stated initially when increasing stimulation on new program that they were feeling a little tingling but then stated they no longer felt stimulation as they continued increasing.Pt stated they were not feeling stimulation, but stated they think it will be ok at this setting.Reviewed therapy/stimulation overview/expectations.The pt provided event date as "it's been afew days".Pt stated they did not have their equipment with them at the hospital.The pt stated when in the hospital they had a test done that they think was an ultrasound of their chest.Agent did not ask about the circumstances that led to the reported issue.The issue was not resolved through troubleshooting.Patient will maintain stimulation level and will continue to track symptoms.
|
B3: date is estimated; month and year are valid.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|